A genetic variant associated with aquaporin 3 expression is correlated to in-hospital death in COVID-19 patients with extracellular hyperosmolality
Hyperosmolality is increasingly recognized as a factor contributing to severe COVID-19. Recently, a genetic variant near the aquaporin 3 (<i>AQP3</i>) water channel was associated with severe COVID-19 [rs60840586:G; odds ratio (OR): 1.07, <i>P</i> = 2.5 × 10<sup>-9</sup>]. The variant is known to increase gene expression of AQP3 in several organs, including the lung [normalized expression scores (NES) = 0.33, <i>P</i> = 4.1 × 10<sup>-20</sup>] in GTEx. In this study, we investigated 576 patients in the Biobanque Quebecoise de la COVID-19 (BQC-19) with both genetic and clinical data available. We estimated plasma osmolality using the formula: eOSM = 2 × [Na<sup>+</sup>] + 2 × [K<sup>+</sup>] + [Urea] + [Glucose]. Using a logistic regression of mortality against eOSM, genotype at rs60840586, sex, age, and the first 10 genetic principal components, we confirm that hyperosmolality is associated with COVID-19 mortality (OR = 2.06 [95% CI = 1.62-2.65], <i>P</i> = 9.13 × 10<sup>-9</sup>). Interestingly, we found that the risk of death linked to hyperosmolality is influenced by the <i>AQP3</i> variant rs60840586:G genotype (OR = 1.95 [95% CI = 1.22-3.28], <i>P</i> = 0.0075). However, the rs60840586 genotype did not independently affect mortality in this cohort. These findings suggest that the body's ability to regulate and accommodate hyperosmolality may be disrupted by overexpression of <i>AQP3</i>, potentially worsening outcomes in COVID-19. Given the role of AQP3 in water transport and homeostasis, further defining the functionality of its variants may provide key insights into COVID-19 severity and guide clinical management strategies, particularly in critically ill patients with hyperosmolality.<b>NEW & NOTEWORTHY</b> A genetic variant near water channel <i>AQP3</i>, linked to severe COVID-19, amplifies the risk of death in patients with elevated plasma osmolality. In patients hospitalized with COVID-19, we show that although the variant does not affect systemic osmolality directly, it interacts with hyperosmolality to increase mortality risk. These findings highlight a potential mechanism where AQP3 overexpression disrupts cellular water handling during critical illness, offering new insight into the role of water balance in COVID-19 pathophysiology.
Authors
- Tianyuan Lu (ORCID: https://orcid.org/0000-0002-5664-5698)
- Satoshi Yoshiji (ORCID: https://orcid.org/0000-0001-8863-2413)
- Amanda Marks (ORCID: https://orcid.org/0000-0002-3961-8831)
- J. Brent Richards (ORCID: https://orcid.org/0000-0002-3746-9086)
- Hugo Zeberg (ORCID: https://orcid.org/0000-0001-7118-1249)
- Michael Hultström (ORCID: https://orcid.org/0000-0003-4675-1099)
- Miklós Lipcsey (ORCID: https://orcid.org/0000-0002-1976-4129)
- Vincenzo Forgetta (ORCID: https://orcid.org/0000-0002-6061-4720)
- Tomoko Nakanishi (ORCID: https://orcid.org/0000-0001-9510-5646)
- Yossi Farjoun (ORCID: https://orcid.org/0000-0002-7002-2868)
- David Morrison (ORCID: https://orcid.org/0000-0001-8380-3615)
- Robert Frithiof (ORCID: https://orcid.org/0000-0003-2278-7951)
- Guillaume Butler‐Laporte (ORCID: https://orcid.org/0000-0001-5388-0396)
- Yiheng Chen (ORCID: https://orcid.org/0000-0002-7662-9441)
Institutions
- Broad Institute (US)
- Uppsala University (SE)
- King's College London (GB)
- Kyoto University (JP)
- Karolinska Institutet (SE)
- Fulcrum Therapeutics (United States) (US)
- Max Planck Institute for Evolutionary Anthropology (DE)
- McGill University (CA)
Publication Details
- Journal
- Physiological Genomics
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1152/physiolgenomics.00174.2024
- Primary Topic
- Ion Transport and Channel Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00